Latest Breaking News On - Neurogene inc - Page 1 : comparemela.com

Avidity Partners Management LP Invests $9.04 Million in Neurogene Inc. (NASDAQ:NGNE)

Avidity Partners Management LP bought a new position in Neurogene Inc. (NASDAQ:NGNE – Free Report) during the 4th quarter, Holdings Channel reports. The firm bought 466,243 shares of the company’s stock, valued at approximately $9,036,000. Avidity Partners Management LP owned about 0.20% of Neurogene as of its most recent SEC filing. Separately, BML Capital Management […]

William-blair
Leerink-partnrs
Robertw-baird
Holdings-channel
Capital-management
Neurogene-inc
Nasdaq
Avidity-partners-management
Free-report
Partners-management
Stock-down
Get-free-report

Neurogene: Q1 Earnings Snapshot - MarketScreener

Neurogene: Q1 Earnings Snapshot - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Neurogene-inc
Zacks-investment-research
Investment-research
Automated-insights

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia
Houston
Texas
United-states
Australian
American
Rachel-mcminn
Human-research-ethics-committee
Neurogene-inc
American-society-of-gene
Drug-administration
Exchange-commission

Neurogene Inc. Optimistic on NGN-401 Trial Progress

Neurogene Inc. Optimistic on NGN-401 Trial Progress
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Neurogene-inc

Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $48.25

Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $48.25
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William-blair
Leerink-partnrs
Neurogene-inc
Sg-americas-securities
Neurogene-company-profile
Nasdaq
Privium-fund-management-united-kingdom-ltd
Great-point-partners
Capital-management
Get-free-report
Fund-management-united-kingdom-ltd
Partners-management